Spots Global Cancer Trial Database for Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Official Title: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Study ID: NCT02298270
Study Description
Brief Summary: This study tests the efficacy of an 8-week, Skype-based, group resiliency training intervention (The Relaxation Response Resiliency Program) for improving psychological stress in patients with Neurofibromatosis. A control group will receive a general health education curriculum. The investigators hypothesize that patients will improve on measures of psychological stress as a result of the resiliency program. A substudy (Unique Protocol ID: 2013P002605b) has been approved to test this study on a sub-population: patients with NF2 who are hard of hearing.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact Details
Name: Ana-Maria Vranceanu, PhD
Affiliation: MGH
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
